Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Tingting Zhang, Li Liu, Xiaohui Zheng, Biao Shen, Ming Gong, Xin Liu, Gang Li, Ying Zhang, Wenbin Cao, Chen Liang, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2828.

https://doi.org/10.1182/blood-2024-209406

Published: 2024

Journal Articles

Efficacy and Safety of a Modified Conditioning Regimen Based on Mitoxantrone Hydrochloride Liposome and Busulfan/Cyclophosphamide for Patients with Refractory and Relapsed Acute Myeloid Leukemia

Chen Liang, Donglin Yang, Yi He, Aiming Pang, Xiaohui Zheng, Gang Li, Mingzhe Han, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 2127.

https://doi.org/10.1182/blood-2024-205285

Published: 2024

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

Daratumumab for Treatment of Epstein-Barr Virus-Associated Post -Transplant Lymphocyte Proliferative Disease after Rituximab Treatment Failure

Gang Li, Donglin Yang, Sizhou Feng, Erlie Jiang, Xin Liu, Chen Liang, Yi He

Blood (2024) 144 (Supplement 1): 7391.

https://doi.org/10.1182/blood-2024-207492

Published: 2024

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Dewan Zhao, Wenbin Cao, Gang Li, Ying Zhang, Xiaohui Zheng, Xin Chen, Weihua Zhai, Qiaoling MA, Rongli Zhang, Jialin Wei, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2024-205145

Published: 2024

Journal Articles

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Sizhou Feng, Yi He, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7366.

https://doi.org/10.1182/blood-2024-207353

Published: 2024

Journal Articles

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia: The Short-TERM Analysis

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Mingzhe Han, Sizhou Feng, Yi He, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7318.

https://doi.org/10.1182/blood-2024-207762

Published: 2024

Journal Articles

Incidence, Risk Factors, Microbiology and Outcomes of Bloodstream Infection during Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation

Ling Pan, Li Jia, Xiaomeng Feng, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7287.

https://doi.org/10.1182/blood-2024-204385

Published: 2024

Journal Articles

Clinical and Genetic Profiles and Outcomes of Allogeneic HSCT in Secondary Myelodysplastic Syndrome Following Aplastic Anemia

Li Jia, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7423.

https://doi.org/10.1182/blood-2024-198333

Published: 2024

Journal Articles

Clinical Characteristics and Treatment Response of Chronic Disseminated Candidiasis in Patients with Hematological Disorders

Zhangjie Chen, Sizhou Feng, Xin Chen, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7683.

https://doi.org/10.1182/blood-2024-194289

Published: 2024

Journal Articles

Clinical Characteristics, Molecular Features and Transplantation Outcomes in MDS with Low Blasts and without Defining Genetic Abnormalities: An Analysis of MDS-h and MDS-LB Patients

Wenjing Guo, Li Jia, Yingchang Mi, Sizhou Feng

Blood (2024) 144 (Supplement 1): 7444.

https://doi.org/10.1182/blood-2024-210574

Published: 2024

Journal Articles

Epidemiological Characteristics and Drug-Resistance Genotype of CRE in Patients with Hematological Diseases in a Single Center of China

Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5841.

https://doi.org/10.1182/blood-2023-188528

Published: 2023

Journal Articles

Haematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anaemia: Clinical Characteristics, Outcomes and Risk Factors

Li Jia, Yilin Liu, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7105.

https://doi.org/10.1182/blood-2023-188427

Published: 2023

Journal Articles

Evaluation of Platelet and Clotting Parameters in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Patients with Candidemia

Hongchen Bi, Xiaoli Luo, Haozhi Zhang, Mingyang Wang, Aiming Pang, Sizhou Feng, Erlie Jiang, Yujie Cui

Blood (2023) 142 (Supplement 1): 5441.

https://doi.org/10.1182/blood-2023-188010

Published: 2023

Journal Articles

Comparison of Hematopoietic Stem Cell Transplantation and Repeated Immunosuppressive Therapy As Second-Line Treatment for Relapsed/Refractory Severe Aplastic Anemia

Lining Zhang, Jianping Li, Weiru Liang, Jialin Wei, Yi He, Erlie Jiang, Fengkui Zhang, Mingzhe Han, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7095.

https://doi.org/10.1182/blood-2023-179202

Published: 2023

Journal Articles

Risk Factors and Prognostic Scoring Model for 28-Day Mortality in Hematologic Patients with Stenotrophomonas M altophilia B acteremia

Wenjing Guo, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7430.

https://doi.org/10.1182/blood-2023-185820

Published: 2023

Journal Articles

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2023-188534

Published: 2023

Journal Articles

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Xiaoyu Zhang, Donglin Yang, Aiming Pang, Yi He, Jialin Wei, Rongli Zhang, Weihua Zhai, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2023-182816

Published: 2023

Journal Articles

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Runzhi Ma, Sisi Zhen, Li Liu, Jieru Wang, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7094.

https://doi.org/10.1182/blood-2023-190923

Published: 2023

Journal Articles

Is Short-Course Antibiotic Therapy Suitable for Pseudomonas Aeruginosa Bloodstream Infections in Onco-Hematology Patients with Febrile Neutropenia? Results of a Multi-Institutional Analysis

Xiaomeng Feng, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5919.

https://doi.org/10.1182/blood-2023-188177

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Efficacy and Safety of a Modified Conditioning Regimen Based on Mitoxantrone Hydrochloride Liposome and Busulfan/Cyclophosphamide for Patients with Refractory and Relapsed Acute Myeloid Leukemia

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Daratumumab for Treatment of Epstein-Barr Virus-Associated Post -Transplant Lymphocyte Proliferative Disease after Rituximab Treatment Failure

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

The Efficacy and Safety of the Addition of Mitoxantrone Hydrochloride Liposome in Conditioning Regimen for High-Risk Acute Myeloid Leukemia: The Short-TERM Analysis

Incidence, Risk Factors, Microbiology and Outcomes of Bloodstream Infection during Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation

Clinical and Genetic Profiles and Outcomes of Allogeneic HSCT in Secondary Myelodysplastic Syndrome Following Aplastic Anemia

Clinical Characteristics and Treatment Response of Chronic Disseminated Candidiasis in Patients with Hematological Disorders

Clinical Characteristics, Molecular Features and Transplantation Outcomes in MDS with Low Blasts and without Defining Genetic Abnormalities: An Analysis of MDS-h and MDS-LB Patients

Epidemiological Characteristics and Drug-Resistance Genotype of CRE in Patients with Hematological Diseases in a Single Center of China

Haematopoietic Stem Cell Transplantation for Hepatitis-Associated Aplastic Anaemia: Clinical Characteristics, Outcomes and Risk Factors

Evaluation of Platelet and Clotting Parameters in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Patients with Candidemia

Comparison of Hematopoietic Stem Cell Transplantation and Repeated Immunosuppressive Therapy As Second-Line Treatment for Relapsed/Refractory Severe Aplastic Anemia

Risk Factors and Prognostic Scoring Model for 28-Day Mortality in Hematologic Patients with Stenotrophomonas M altophilia B acteremia

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Is Short-Course Antibiotic Therapy Suitable for Pseudomonas Aeruginosa Bloodstream Infections in Onco-Hematology Patients with Febrile Neutropenia? Results of a Multi-Institutional Analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only